It always seemed weird to me that pharmaceutical companies could pay doctors to prescribe medicines—and, yes, that will go on—but GlaxoSmithKline has taken a big step towards limiting that compensation. Over on LXBN TV, former National Labor Relationship General Counsel Ronald Meisburg joins me to discuss two stories impacting the NLRB.

For more of the best, check out LXBN, a complete review of the top insight and commentary across the LexBlog Network.